Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin

Vaccine

Volumn 14, Issue 2, 1996, Pages 113-119

  Hashigucci, Kazuhiro ^a   Ogawa, Hiroshi ^a   Ishidate, Takeo ^a   Yamashita, Ryoko ^a   Kamiya, Hitoshi ^b   Watanabe, Kouji ^c   Hattori, Nobuaki ^c   Sato, Takaaki ^c   Suzuki, Yujiro ^c   Nagamine, Takashi ^c   Aizawa, Chikara ^c   Tamura, Shin Ichi ^d   Kurata, Takeshi ^d   Oya, Akira ^d  

^a KITASATO INSTITUTE HOSPITAL   (Japan)

^b MIE NATIONAL HOSPITAL   (Japan)

^c KITASATO INSTITUTE   (Japan)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Escherichia coli heat labile enterotoxin; Nasal influenza vaccine; Volunteers

Indexed keywords

ENTEROTOXIN B; ESCHERICHIA COLI ENTEROTOXIN; HOLOTOXIN; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; SECRETORY IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ADULT; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESCHERICHIA COLI; HUMAN; HUMAN EXPERIMENT; IMMUNIZATION; INFLUENZA; INTRANASAL DRUG ADMINISTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SALIVA;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADULT; ANTIBODIES, VIRAL; BACTERIAL TOXINS; ENTEROTOXINS; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FEMALE; GLYCOSIDES; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS, VIRAL; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; INFLUENZA VACCINES; MALE; MIDDLE AGED; RADIATION-SENSITIZING AGENTS; SALIVA; TRITERPENES; VACCINES, COMBINED;

EID: 0029959974     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(95)00174-Y     Document Type: Article

References (10)

1. Murphy, B.R. and Webster, R.G. Orthomyxoviruses. In: Virology (Eds Fields, B.N., Knipe, D.M., Chanock, R.M., Hirsch, M.S. and Melnick, J.L.). Raven Press, New York, 1990, p. 1091
2. Mann, J.J., Waldman, R.H., Togo, Y., Heiner, G.G., Dawkins, A.T. Jr and Kasel, J.A. Antibody response in respiratory secretions of volunteers given live and dead influenza virus. J. Immunol. 1968, 100, 726
3. Waldman, R.H., Wigley, F.M. and Small, P.A. Jr. Specificity of respiratory secretion antibody against influenza virus. J. Immunol. 1970, 105, 1477
4. Liew, F.Y, Russell, S.M., Appleyard, G., Brand, C.M. and Beale, J. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell activity. Eur. J. Immunol. 1984, 14, 350
5. Tamura, S.-I., Samegai, Y., Kurata, H., Nagamine, T., Aizawa, C. and Kurata, T. Protection against influenza virus infection by vaccine inoculate intranasally with cholera toxin B subunit. Vaccine 1988, 6, 409
6. Tamura, S.-I., Ito, Y., Asanuma, H. et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J. Immunol. 1992, 149, 981
7. Tamura, S.-I., Asanuma, H., Tomita, T. et al. Escherichia coli heat-labile enterotoxin B subunit supplemented with a trace amount of the holotoxin as an adjuvant for nasal influenza vaccine. Vaccine 1994, 12, 1083
8. Hierholzer, J.C. and Suggs, M.T. Standardized viral hemagglutination and hemagglutination-inhibition tests. I. standardization of erythrocyte suspensions. Appl. Microbial. 1969, 18, 816
9. Sugiura, A., Yanagawa, H., Enomoto, C. et al. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2/Hong Kong and B influenza viruses. J. Infect. Dis. 1970, 122, 472
10. Kuno-Sakai, H., Kimura, M., Ohta, K., Shimojima, R., Oh, Y. and Fukumi, H. Development in mucosal influenza virus vaccines. Vaccine 1994, 12, 1303